What is Breast Cancer?
Breast cancer occurs when cells in the breast grow uncontrollably and form a tumour. It is the most commonly diagnosed cancer in Filipino women. While it predominantly affects women, men can also develop breast cancer — though this is rare.
Breast cancer is highly treatable, especially when caught early. With modern medicine — including targeted therapies and advanced surgical techniques — many women go on to live full, healthy lives after treatment.
📌 Tandaan: Ang regular na mammogram at self-breast exam ay mahalaga para sa maagang pagtuklas. Kung may naramdaman kang bukol o pagbabago sa iyong dibdib, kumonsulta kaagad sa doktor.
Types of Breast Cancer
Invasive Ductal Carcinoma (IDC)
The most common type, accounting for about 80% of all breast cancers. It starts in the milk ducts and grows into surrounding breast tissue.
Invasive Lobular Carcinoma (ILC)
Starts in the milk-producing glands (lobules) and spreads to nearby tissue. It is the second most common type.
HER2-Positive Breast Cancer
A subtype where cancer cells have too many copies of the HER2 protein, causing faster growth. Targeted therapies (like trastuzumab/Herceptin) are highly effective for this type.
Triple-Negative Breast Cancer (TNBC)
A subtype that does not respond to hormonal therapy or HER2-targeted drugs. It is more common in younger women and tends to grow faster, but it does respond well to chemotherapy. Immunotherapy is also emerging as an option.
Hormone Receptor-Positive Breast Cancer
The most common subtype overall, where tumour cells respond to the hormones oestrogen and/or progesterone. Hormone therapy is highly effective for this type.
Common Symptoms to Watch For
- A new lump or thickening in the breast or underarm area
- Changes in the size, shape, or appearance of the breast
- Dimpling, puckering, or skin that looks like orange peel on the breast
- A newly inverted (pulled inward) nipple
- Nipple discharge (other than breast milk), especially if bloody
- Redness, soreness, or rash on the skin covering the breast
- Swelling of all or part of the breast, even without a distinct lump
Diagnosis
If symptoms are present or a screening mammogram is abnormal, your doctor may recommend:
- Diagnostic mammogram — A more detailed X-ray of the breast
- Ultrasound — Uses sound waves to determine if a lump is solid or filled with fluid
- MRI (Magnetic Resonance Imaging) — Provides detailed images of breast tissue
- Biopsy — Removal and examination of tissue to confirm cancer. The biopsy also reveals the cancer's receptor status (ER, PR, HER2) which guides treatment.
Staging
Breast cancer is staged from 0 to IV based on tumour size, lymph node involvement, and whether it has spread.
- Stage 0: Ductal Carcinoma In Situ (DCIS) — non-invasive, highly treatable
- Stage I–II: Early-stage, often treated with surgery, possibly followed by radiation and/or systemic therapy
- Stage III: Locally advanced. Multi-modal treatment including chemotherapy, surgery, and radiation
- Stage IV (Metastatic): Has spread to other organs. Treatment focuses on controlling the disease and maintaining quality of life
Treatment Options
Surgery
Options include lumpectomy (removing only the tumour and a small margin) or mastectomy (removing one or both breasts). Sentinel lymph node biopsy checks whether cancer has spread to lymph nodes.
Radiation Therapy
Often used after lumpectomy to reduce the risk of recurrence. It targets any remaining cancer cells in the breast area.
Chemotherapy
May be given before surgery (neoadjuvant) to shrink a tumour, or after surgery (adjuvant) to lower recurrence risk. Also used for metastatic breast cancer to slow progression.
Hormone (Endocrine) Therapy
For hormone receptor-positive cancers, drugs like tamoxifen and aromatase inhibitors block hormones that fuel cancer growth. This is often taken for 5–10 years after primary treatment.
Targeted Therapy
For HER2-positive cancers, drugs like trastuzumab (Herceptin), pertuzumab, and T-DM1 target the HER2 protein. CDK4/6 inhibitors are also highly effective for hormone receptor-positive, metastatic disease.
Immunotherapy
For triple-negative breast cancer, immunotherapy drugs like pembrolizumab (Keytruda) have shown promising results in combination with chemotherapy.
🌟 Advanced Care in China: China's leading oncology centres offer access to newer targeted drugs, clinical trials, and comprehensive multidisciplinary care — including breast reconstruction options and survivorship support. Our coordinators can arrange a case review with a specialist.
Life After Treatment
Many breast cancer survivors go on to live long, healthy lives. Follow-up care typically includes regular mammograms, check-ups, and in some cases, ongoing hormonal therapy. Psychological support, nutrition guidance, and survivorship programmes are also important parts of recovery.
Request a Breast Cancer Consultation
Our partner Chinese oncologists include specialists in breast cancer who can review your pathology report and treatment history and offer a second opinion.
Register as a Patient